Cesamet (Meda Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Cesamet drug offered from Meda Pharmaceuticals Inc.. This Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Meda Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | Nabilone |
| SUBSTANCE NAME: | NABILONE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cannabinoid [EPC],Cannabinoids [Chemical/Ingredient] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2010-03-01 |
| END MARKETING DATE: | 0000-00-00 |
Cesamet HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cesamet from Meda Pharmaceuticals Inc. |
| LABELER NAME: | Meda Pharmaceuticals Inc. |
| DEA SCHEDULE: | CII
|
| ACTIVE STRENGTH: | 1(mg/1) |
| START MARKETING DATE: | 2010-03-01 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0037-1221_70568880-5589-40c0-88f8-1721eef4a8a0 |
| PRODUCT NDC: | 0037-1221 |
| APPLICATION NUMBER: | NDA018677 |
Other NABILONE Pharmaceutical Manufacturers / Labelers:
